6199-67-3|(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate|BLD Pharm

Startseite/ Inhibitors/Agonists/ Cell Cycle/ Microtubule/Tubulin/(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate *Cold-chain transportation

CAS NO.： 6199-67-3

Größe	Preis	Verkaufsrabatt	Rabatt	Lager-CN	Lager-US	Lager-IND	Lager-EU	Menge

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

PRODUKT INFORMATION

Produktdetails
Sicherheit

Produkt Name :	(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
CAS Nr. :	6199-67-3	Molekulargewicht :	558.70
MDL Nr. :	MFCD07778083	Feinheit/Spezifikation :
Molekularformel :	C₃₂H₄₆O₈	Lagerung :	Keep in dark place,Sealed in dry,2-8°C
Siedepunkt :	No data available

GHS Pictogram :
Signal Word :	Danger	Precautionary Statements :	P264-P270-P301+P310+P330-P405-P501
UN# :	2811	Class :	6.1
Hazard Statements :	H300	Packing Group :	Ⅱ

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate *Cold-chain transportation

PRODUKT INFORMATION

ZUSAMMENHÄNGENDE PRODUKTE

HISTORISCHE AUFZEICHNUNGEN

Kontakt